Modulation of the Receptor Tyrosine Kinase TIE2/Tek Pathway by NRF2 Activation in Neurovascular Endothelial Cells
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27020770 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Eduardo Cazalla und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Medicine, Autonomous University of Madrid (UAM), 28049 Madrid, Spain. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Receptor, TIE-2, Endothelial Cells, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Economy and Competitiveness, Comunidad de Madrid, Instituto de Salud Carlos III.
Abstract (Originalsprache)
The transcription factor NRF2 orchestrates diverse cellular homeostatic networks, but its role in angiogenesis remains poorly understood. Genetic and pharmacological modulation of NRF2 in mouse neuroendothelial cells altered the expression of several genes involved in endothelial biology. Among these, the TIE2/Tek receptor, essential for vascular development and integrity, was downregulated upon NRF2 activation, accompanied by changes in adherens and tight junction gene expression. Hemin treatment and knockdown revealed that TIE2/Tek repression is independent of the NRF2 repressor BACH1. mRNA stability and ChIP analyses indicated no post-transcriptional or direct transcriptional repression by NRF2. These findings suggest an alternative NRF2-dependent mechanism affecting TIE2/Tek levels and potentially influencing angiogenic regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, School of Medicine, Autonomous University of Madrid (UAM), 28049 Madrid, Spain.
- Instituto de Investigaciones Biomédicas "Sols-Morreale" (CSIC-UAM), 28029 Madrid, Spain.
- Instituto de Investigación Sanitaria La Paz (IdiPaz), 28046 Madrid, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), 28046 Madrid, Spain.
- Group of Neurodegenerative Diseases, Hospital Universitario 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.
ORCID-Profile: Eduardo Cazalla, Ángel Juan García-Yagüe, José Jiménez-Villegas, Maribel Escoll, Ana I Rojo, Antonio Cuadrado
Förderung
- Spanish Ministry of Economy and Competitiveness
- Comunidad de Madrid
- Instituto de Salud Carlos III
- Autonomous Community of Madrid
- Ministry of Universities
- Miguel Servet complementary financing
Zitieren
APA
Cazalla, E., García-Yagüe, Á. J., Pajares, M., Jiménez-Villegas, J., Escoll, M., Rojo, A. I., & Cuadrado, A. (2026). Modulation of the Receptor Tyrosine Kinase TIE2/Tek Pathway by NRF2 Activation in Neurovascular Endothelial Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020770
Vancouver
Cazalla E, García-Yagüe ÁJ, Pajares M, Jiménez-Villegas J, Escoll M, Rojo AI, et al. Modulation of the Receptor Tyrosine Kinase TIE2/Tek Pathway by NRF2 Activation in Neurovascular Endothelial Cells. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020770
BibTeX
@article{Cazalla2026,
author = {Cazalla, Eduardo and García-Yagüe, Ángel Juan and Pajares, Marta and Jiménez-Villegas, José and Escoll, Maribel and Rojo, Ana I and Cuadrado, Antonio},
title = {Modulation of the Receptor Tyrosine Kinase TIE2/Tek Pathway by NRF2 Activation in Neurovascular Endothelial Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27020770}
}
EUVIMED